Holy Mackerel! This week we will discuss fish oil use in maintenance hemodialysis patients. Could this be the one thing that bends the curve on CV mortality, or is it just a red herring?
This week, we will discuss the phase 3 ORIGIN3 trial of atacicept, an APRIL/BAFF inhibitor for use in IgAN.
Day 3 of Kidney Week. Sibeprenlimab and Balcinrenone on NEJM and Lancet, plus a couple of other non-kidneywk studies.
in this edition: Fish Oil, GBD, Flozination meta-analysis, CHW intervention in Hispanic/Latino patients, and much more
RCT of PO sodium bicarbonate in patients with renal transplant to see if impacts stability of renal function - catch up here!
Welcome to #TenTweetNephJC
— Nephrology Journal Club (@NephJC) June 16, 2023
We bring to you today a treatment suggested (2B) by KDIGO to be beneficial in slowing eGFR decline of non-Transplant patients, and evaluate its evidence in the Tx cohort.
Does NaHCO3 Preserve-Transplant function? 🧵
✳️ 10 tweets #NephJC catch-up ✳️ pic.twitter.com/vSgmerzo2o
Another home run, from Divya Bajpai
